6.2 KiB
| title | chunk | source | category | tags | date_saved | instance |
|---|---|---|---|---|---|---|
| Biopsychiatry controversy | 2/2 | https://en.wikipedia.org/wiki/Biopsychiatry_controversy | reference | science, encyclopedia | 2026-05-05T09:09:04.639948+00:00 | kb-cron |
=== Reductionism === Niall McLaren emphasizes in his books Humanizing Madness and Humanizing Psychiatry that the major problem with psychiatry is that it lacks a unified model of the mind and has become entrapped in a biological reductionist paradigm. The reasons for this biological shift are intuitive, as reductionism has been very effective in other fields of science and medicine. However, despite reductionism's efficacy in explaining the smallest parts of the brain, this does not explain the mind, which is where he contends the majority of psychopathology stems from. An example would be that every aspect of a computer can be understood scientifically down to the last atom; however, this does not reveal the program that drives this hardware. He also argues that the widespread acceptance of the reductionist paradigm leads to a lack of openness to Self-criticism, "a smugness that stops the very engine of scientific progress." He has proposed his own natural dualist model of the mind, the biocognitive model, which is rooted in the theories of David Chalmers and Alan Turing and does not fall into the "dualist's trap" of spiritualism.
== Economic influences on psychiatric practice == American Psychiatric Association president Steven S. Sharfstein, M.D. has stated that when the profit motive of pharmaceutical companies and human good are aligned, the results are mutually beneficial for all: "Pharmaceutical companies have developed and brought to market medications that have transformed the lives of millions of psychiatric patients. The proven effectiveness of antidepressant, mood-stabilizing, and antipsychotic medications has helped sensitize the public to the reality of mental illness and taught them that treatment works. In this way, Big Pharma has helped reduce stigma associated with psychiatric treatment and with psychiatrists." However, Sharfstein acknowledged that the goals of individual physicians who deliver direct patient care can be different from the pharmaceutical and medical device industry. Conflicts arising from this disparity raise natural concerns in this regard including:
a "broken health care system" that allows "many patients [to be] prescribed the wrong drugs or drugs they don't need"; "medical education opportunities sponsored by pharmaceutical companies [that] are often biased toward one product or another"; "[d]irect marketing to consumers [that] also leads to increased demand for medications and inflates expectations about the benefits of medications"; "drug companies [paying] physicians to allow company reps to sit in on patient sessions to learn more about care for patients." Nevertheless, Sharfstein acknowledged that without pharmaceutical companies developing and producing modern medicines - virtually every medical specialty would have few (if any) treatments for the patients that they care for.
=== Pharmaceutical industry influences in psychiatry === Studies have shown that promotional marketing by pharmaceutical and other companies has the potential to influence physicians' decision making. Pharmaceutical manufacturers (and other advocates) would argue that in today's modern world, physicians simply do not have the time to continually update their knowledge base on the status of the latest research; that by providing educational materials for both physicians and patients, they are providing an educational perspective; and that it is up to the individual physician to decide what treatment is best for their patients. has been replaced by educationally-based activities that became the basis for the legal and industry reforms involving physician gifts, influence in graduate medical education, physician disclosure of conflicts of interest, and other promotional activities. In an essay on the effect of advertisements on sales for marketed anti-depressants, evidence showed that both patients and physicians can be influenced by media advertisements, and that this influence has the possibility of increasing the frequency of certain medicines being prescribed over others.
== See also ==
=== General === Anti-psychiatry – A movement critiquing psychiatry from a human rights perspective. Bipolar disorders research – biopsychiatric analysis into the cause of bipolar disorders. Elliott Valenstein – a psychologist and neuroscientist, author of Blaming the Brain. The Gene Illusion – a book by clinical psychologist Jay Joseph. Causes of schizophrenia Controversy about ADHD A Brief History of Anxiety (Yours & Mine), a book by journalist Patricia Pearson Trauma model of mental disorders Interpretation of Schizophrenia – Award-winning book by Silvano Arieti, which sets forth demonstrative evidence of a psychological etiology for schizophrenia.
=== Groups critical of the biomedical paradigm === Mindfreedom – A group that advocates "choice" regarding psychopharmaceuticals. ICSPP (International Center for the Study of Psychiatry and Psychology) ISPS (International Society for Psychological and Social Approaches to Psychoses) CEP (Council for Evidence-based Psychiatry)
== External links ==
=== Criticisms from psychologists and the medical profession === APA Fights Attempt to Limit Access to Psychoactive Drugs, American Psychiatric Association president Michelle Riba, M.D., M.S. Commentary: Against Biologic Psychiatry, an article by David Kaiser, M.D., in Psychiatric Times (1996, Vol. XIII, Issue 12). Challenging the Therapeutic State – special issue of The Journal of Mind and Behavior (1990, Vol.11:3). Letter of Resignation from the American Psychiatric Association – from Loren R. Mosher, M.D., former Chief of Schizophrenia Studies at the National Institute of Mental Health. Memorandum from the Critical Psychiatry Network to the United Kingdom Parliament – Written evidence to the House of Commons Select Committee on Health, April 2005.
=== Methodological issues === On the Limits of Localization of Cognitive Processes in the Brain – an essay by William R. Uttal, Professor Emeritus of Psychology at the University of Michigan, based on his book The New Phrenology (MIT Press, 2001).
== References ==